Revolution Medicines, Inc.
RVMD
$203.71
$1.710.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -41.99% | -24.37% | -19.56% | -23.17% | -16.11% |
| Total Depreciation and Amortization | -0.77% | -1.46% | 13.97% | 12.10% | 5.44% |
| Total Amortization of Deferred Charges | -- | -- | -66.67% | 50.00% | -33.33% |
| Total Other Non-Cash Items | 111.92% | 108.66% | 44.71% | 39.89% | 106.82% |
| Change in Net Operating Assets | 188.96% | -152.55% | -42.87% | 1,411.71% | -276.57% |
| Cash from Operations | -9.36% | -29.15% | -32.28% | 6.51% | -14.05% |
| Capital Expenditure | -48.63% | 20.10% | 42.52% | 55.05% | -128.11% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,051.11% | 126.74% | 172.38% | -32.42% | 428.99% |
| Cash from Investing | -1,060.91% | 130.52% | 201.35% | -27.50% | 314.91% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 606.67% | -34.61% | 8,710.70% | -36.97% | 637.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 97,127.38% | -231.94% | 103.33% | -102.30% | 1,389,000.00% |
| Cash from Financing | 913.84% | -34.71% | 23,068.53% | -100.62% | 29,257.32% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 554.78% | -65.61% | 190.36% | -366.35% | 132.98% |